Catalyst
Slingshot members are tracking this event:
AMAG Pharmaceuticals expects FDA action and commercial launch of Feraheme, treatment for Adults with Iron Deficiency Anemia (IDA) in Q2 of 2018
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AMAG | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 03, 2018
Occurred Source:
https://www.amagpharma.com/news/amag-pharmaceuticals-announces-first-quarter-2018-financial-results-and-raises-full-year-financial-guidance/
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Fda Review, Commerical Launch, Feraheme, Iron Deficiency Anemia
